BackZosano Pharma Overview

Zosano Pharma Other Assets

Latest other assets for ZSAN: $0.

Get informed when a big investor buys or sells

+ Follow
Other Assets
$0.00

Peer average

Loading

Zosano Pharma Other Assets History

Loading

Zosano Pharma vs. peers: Other Assets Comparison

Loading

Zosano Pharma Other Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Zosano Pharma (ZSAN) FAQ

Zosano Pharma (ZSAN) currently reports a other assets of $0 as of March 2022. In the prior-year period, the figure was $0. Use the charts on this page to explore Zosano Pharma's other assets history and peer comparisons.

Zosano Pharma's other assets changed from $0 to $0 (period ending March 2022). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Zosano Pharma reported $0 in other assets as of March 2022. In the prior-year period, the figure was $0. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current other assets of $0, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Zosano Pharma, and consider following ZSAN for alerts when major investors trade the stock.

Zosano Pharma is classified in the Healthcare sector. On other assets, it currently shows $0. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing ZSAN with unrelated industries.